NonDpharmaceutical correction of intravascular platelet activity in hypertensive patients

NonDpharmaceutical correction of intravascular platelet activity in hypertensive patients

Hypocaloric diet and individually tailored physical activity in patients with arterial hypertension and metabolic syndrome normalized lipid profile, intravascular platelet activity, and decreased peroxidation intensity. These positive effects were maximal at Week 24, but still didn't reach cont...

Full description

Saved in:

Bibliographic Details
Main Author:	I. N. Medvedev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2005-10-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension metabolic syndrome hypocaloric diet physical activity platelets
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2358
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rapid normalization of platelet hemostasis in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-04-01)

Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev
Published: (2006-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2006-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-02-01)

Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome
by: I. N. Medvedev
Published: (2006-06-01)

Increased intravascular platelet activity in metabolic syndrome patients, and its correction by simvastatin treatment
by: N. I. Gromnatsky, et al.
Published: (2004-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
by: I. N. Medvedev, et al.
Published: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01)

Combined effects of aerobic exercise with ketogenic mediterranean and hypocaloric balanced diets on adolescents with polycystic ovarian syndrome
by: Reham Hamoda, et al.
Published: (2025-04-01)

Metabolic Insights and Reproductive Health Challenges: High-Protein Hypocaloric Diets in PCOS Management [Letter]
by: Liu W, et al.
Published: (2025-07-01)

PLATELET HEMOSTASIS DYNAMICS IN SIMVASTATINTREATED PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2010-02-01)

Verospiron effects on platelet aggregation in patients with arterial hypertension and abdominal obesity
by: I. N. Medvedev, et al.
Published: (2007-12-01)

Could micronutrients influence levels of TNF-α expression? A nutrigenomics study through 8-WEEK dietary intervention
by: Isabelle Mello Schineider, et al.
Published: (2025-06-01)

Lisinopril effects on platelet activity in patients with arterial hypertension and impaired glucose tolerance
by: I. N. Medvedev, et al.
Published: (2008-06-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
by: N. J. Gromnazky, et al.
Published: (2003-12-01)

Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome
by: N. M. Krasnova, et al.
Published: (2008-06-01)

Vascular and platelet hemostasis and microcirculation in arterial hypertension patients
by: L. L. Kirichenko, et al.
Published: (2005-08-01)

Efficacy, safety of combined perindopril and indapamide low-dose therapy in patients with arterial hypertension and metabolic syndrome
by: O. N. Andreeva, et al.
Published: (2005-06-01)

DISORDERS OF PLASMA AND PLATELET PATHWAYS OF HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH DISLIPOPROTEINEMIA
by: M. Y. Zhuk, et al.
Published: (2003-10-01)

Essential arterial hypertension in women, or female arterial hypertension?
by: V. I. Podzolkov, et al.
Published: (2012-02-01)

Influence of combined antihypertensive therapy on plasmatic,vascular-thrombocytic hemostasis and lipid peroxidation in patientswith metabolic syndrome and arterial hypertension
by: N. M. Krasnova, et al.
Published: (2007-12-01)

COMPARISON OF OPPORTUNITIES FROM TWO THERAPEUTICAL COMPLEXES FOR CORRECTION OF VASCULAR HEMOSTASIS IN HYPERTENSIVES WITH METABOLIC SYNDROME
by: S. Yu. Zavalishina, et al.
Published: (2017-04-01)

Mediterranean Diet and Metabolic Syndrome
by: Josipa Radić, et al.
Published: (2025-01-01)

Increased risk of platelet thrombosis stimulated by hypomagnesiemia in acute myocardial infarction
by: N. A. Andriadze, et al.
Published: (2004-12-01)

EFFECTIVENESS OF VASCULAR WALL ACTIVITY CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND OCULO-VASCULAR OCCLUSION
by: I. N. Medvedev, et al.
Published: (2010-06-01)

COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION
by: I. N. Medvedev, et al.
Published: (2010-08-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
by: I. E. Chazova, et al.
Published: (2005-12-01)

Association of socio-demographic and dietary factors for metabolic syndrome: A comparative study among tribal and non-tribal population
by: Jayshri R. Ghate, et al.
Published: (2025-07-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
by: L. I. Abasova, et al.
Published: (2011-08-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: V. A. Nevzorova, et al.
Published: (2015-12-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01)

Obesity pharmaceutical correction in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2005-08-01)

Indicators of ADP-induced platelet aggregation in patients with hypertension complicated by ischemic hemisphere stroke
by: V. V. Syvolap, et al.
Published: (2017-10-01)

The epigenetic impact of lifestyle factors on metabolic syndrome: A systematic review
by: Temitope Gabriel Adedeji
Published: (2025-04-01)

Study of platelet activation, hypercoagulable state, and pulmonary hypertension in patients with transfusion-dependent beta-thalassemia
by: Lanja Othman Haji, et al.
Published: (2024-12-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
by: E. G. Ivanova, et al.
Published: (2022-07-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
by: O. A. Osipova, et al.
Published: (2022-10-01)

Blood atherogenic potential as a predictor of arterial hypertension among children living in ecologically unsafe territories of the Moldova Republic
by: L. V. Vasilos, et al.
Published: (2013-06-01)